Assistant Professor of Medicine
BS, Haverford College, 1984
MD, University of Pennsylvania, 1993
University of Virginia Health Sciences Center, Internal Medicine/Primary Care, 1996
Research and Professional Interests
Venous thromboembolic disease, utilization/clinical resource management
Dr. Locke's Publications
Locke C, Moreland C. Venous Thromboembolism Prophylaxis in Total Knee Arthroplasty and Total Hip Arthroplasty. Hospital Medicine Clinics. 2013 Jan;2(1):e91-e102.
Moreland C, Locke C. Venous Thromboembolism Prophylaxis After Nonorthopedic Surgical Procedures. Hospital Medicine Clinics. 2013 Jan;2(1):e117-e129.
Locke CF. Mortality as Primary End Point in Studies of Heparin Thromboprophylaxis [letter]. American Journal of Medicine. 2007 May;120(5):e11.
Locke CF, Dooley J, Gerber J. Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thrombosis Journal. 2005 Apr;3(1):4.
Locke CF, Evans, NC. Evaluating idiopathic venous thromboembolism: what is necessary, what is not. Journal of Family Practice. 2003 Oct;52(10):770-7.
Seo P, Locke CF. Current and potential uses of low molecular weight heparin: a review and an economic analysis. American Journal of Managed Care. 2000;6:498-506.
Locke CF. The True Cost of the Complete Annual Physical Examination [letter]. Archives of Internal Medicine. 1999;159:2601.
Duckworth C, Locke C, Peura D. Does the C14 urea breath test need to be done fasting? [abstract]. Gastroenterology. 1995;108:A85.